<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21731" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fibrocystic Breast Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malherbe</surname>
            <given-names>Kathryn</given-names>
          </name>
          <aff>University of Pretoria</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Myra</given-names>
          </name>
          <aff>University of Michigan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fatima</surname>
            <given-names>Saira</given-names>
          </name>
          <aff>Aga Khan University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kathryn Malherbe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Myra Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Saira Fatima declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21731.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Fibrocystic breast disease is the most common benign type of breast disease, diagnosed in millions of women worldwide. Certain hormonal factors underpin the function, evaluation, and treatment of this disease. Benign breast disease is an umbrella term for various non-malignant lesions, such as tumors, trauma, mastalgia, and nipple discharge. This activity reviews the indications, symptomology, management, and other key elements related to fibrocystic breast disease in the clinical setting related to the essential points needed by members of an interprofessional team managing the care of patients with the condition and sequelae.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the pathophysiology of fibrocystic breast conditions.</p></list-item><list-item><p>Outline the appropriate history, physical, and evaluation of a patient presenting with symptoms associated with benign breast disease.</p></list-item><list-item><p>Review the treatment and management options available for fibrocystic breast disease.</p></list-item><list-item><p>Describe some interprofessional team strategies for improving care coordination and communication to advance patient education regarding this disease and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21731&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21731">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21731.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fibrocystic breast disease is the most common benign type of breast disease, diagnosed in millions of women worldwide. Certain hormonal factors underpin the function, evaluation, and treatment of this disease. Benign breast disease is an umbrella term for various non-malignant lesions, such as&#x000a0;tumors, trauma, mastalgia, and nipple discharge.<xref ref-type="bibr" rid="article-21731.r1">[1]</xref></p>
        <p>The above-mentioned&#x000a0;benign lesions&#x000a0;are not associated with an increased risk for&#x000a0;malignancy; however, it associates with an up to 50% risk of developing breast cancer under certain histopathological and clinical circumstances.<xref ref-type="bibr" rid="article-21731.r2">[2]</xref>&#x000a0;A palpable mass upon clinical evaluation is evident in both benign and malignant breast conditions. The clinical findings include symptoms such as&#x000a0;dimpling of the skin (peau d'orange), thickening,&#x000a0;pain, and nipple discharge.<xref ref-type="bibr" rid="article-21731.r3">[3]</xref></p>
        <p>The most common investigative tools to assess for these clinical findings are&#x000a0;mammograms and ultrasound.<xref ref-type="bibr" rid="article-21731.r4">[4]</xref></p>
        <p>The&#x000a0;main components of the breast are prone to fibrocystic changes during hormonal fluctuations. These components include the stroma, ducts, and lobules of the breast.&#x000a0;During the reproductive age, glandular breast tissue has a direct relation to cyclical surges&#x000a0;of plasma levels of estradiol and progesterone.<xref ref-type="bibr" rid="article-21731.r1">[1]</xref></p>
      </sec>
      <sec id="article-21731.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of benign breast disease has demonstrated a strong clinical association with women receiving estrogen and anti-estrogen treatment. The prevalence of benign breast lesions in postmenopausal women receiving estrogens and progestins for over eight years is increased by 1.7 fold. During the Women&#x02019;s Health Initiative study (WHI), the combined use of estrogen and progestin correlated with a 74% risk of benign breast disease. The use of anti-estrogens led to a&#x000a0;28% reduction in the prevalence of benign proliferative breast disease.<xref ref-type="bibr" rid="article-21731.r5">[5]</xref></p>
        <p>
<bold>Study selection criteria</bold>
</p>
        <p>The analysis used prospective cohort&#x000a0;and&#x000a0;nested case-control studies of at least 300 cases and&#x000a0;meta-analyses.</p>
        <p>
<bold>See Table 1&#x000a0;</bold>
</p>
        <p>* Relative risks estimated from standardized incidence ratios.&#x000a0;</p>
        <p>&#x02020; Controls were women who had non-proliferative benign breast disease.<xref ref-type="bibr" rid="article-21731.r2">[2]</xref>&#x000a0;</p>
        <p>Polycystic ovary syndrome (PCOS) typically presents with factors such as anovulation and hyperandrogenaemia, which is evident in&#x000a0;5 to10% of women within reproductive age.<xref ref-type="bibr" rid="article-21731.r6">[6]</xref></p>
        <p>Previous studies have concluded that&#x000a0;hyperestrogenism and anovulation are associated with&#x000a0;benign breast conditions, as the growth of glandular breast tissue is affected by the levels of estrogen and progesterone in pathological processes.<xref ref-type="bibr" rid="article-21731.r7">[7]</xref></p>
      </sec>
      <sec id="article-21731.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There is varied literature, ranging from 30&#x000a0;to 60% of all women. It is most common in women between the ages of 30&#x000a0;to 50 years.<xref ref-type="bibr" rid="article-21731.r8">[8]</xref></p>
        <p>One of the most common forms of benign breast disease is fibroadenomas, characterized by localized proliferation of breast ducts and stroma.&#x000a0;This subtype&#x000a0;accounts for 70 to 95% of all tumor benign type of breast disease. The incidence is&#x000a0;mostly seen in the 17 to 20 year age group,&#x000a0;extending to 2 years premenarche at 35.<xref ref-type="bibr" rid="article-21731.r3">[3]</xref></p>
      </sec>
      <sec id="article-21731.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Mammary gland development, maturation, and differentiation act upon the hormonal and growth factor changes affecting the stromal and epithelial cells.<xref ref-type="bibr" rid="article-21731.r4">[4]</xref></p>
        <p>During the late proliferative phase, glandular tissue evolves to hyperplastic stages such as sclerosing adenosis or lobular hyperplasia. This state of hyperplasia, if associated with a 2% prevalence of Ki67 cells, has a twofold increased incidence for the development of breast cancer.<xref ref-type="bibr" rid="article-21731.r9">[9]</xref></p>
        <p>Various types of benign breast disease exist, such as hyperplasia, cysts, fibroadenomas, sclerosing adenosis, and mastitis.</p>
      </sec>
      <sec id="article-21731.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>There is a limited pathological consensus regarding the histopathological appearance of benign breast disease.</p>
        <p>The main features are an&#x000a0;extracellular matrix of collagen, peri canalicular patterns of stromal cells with the presence of florid epithelial hyperplasia.</p>
        <p>During the menopausal phase, fibroadenomas involute, which affects&#x000a0;dense collagen stroma and atrophic glands.<xref ref-type="bibr" rid="article-21731.r10">[10]</xref></p>
        <p>Cystic changes derive from the terminal duct lobular unit (TDLU). Due to the expansion of the efferent ductules of the TDLU, cysts form as a result of fluid accumulation in these structures. The lining appears flat with a myoepithelial layer present.<xref ref-type="bibr" rid="article-21731.r5">[5]</xref></p>
        <p>
<bold>Image 3</bold>
</p>
        <p>Microscopic histology section of fibroadenosis</p>
      </sec>
      <sec id="article-21731.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Benign cysts are typically mobile within the glandular breast tissue, chest wall, and skin and are rubber-like in texture. Except for inflammatory type cysts, discomfort and tenderness experienced by a patient are either absent or mild. Most patients present with multiple cysts upon further clinical and diagnostic evaluation.<xref ref-type="bibr" rid="article-21731.r11">[11]</xref></p>
        <p>Various subtypes of cysts are known, including hyperplastic fibrous cysts, adenosis, and papillomatosis. These types of cysts are usually found in the upper outer quadrants of the breast, as well as in the central margins. The texture upon evaluation ranges from a firm texture to multiple subcentimeter cysts.<xref ref-type="bibr" rid="article-21731.r12">[12]</xref></p>
        <p>Fibroadenomas present in varied sizes with a common oval-shaped, well-defined margin. As with cysts, fibroadenomas are mobile upon evaluation and are often multiple, occurring either simultaneously or over a specified period.<xref ref-type="bibr" rid="article-21731.r13">[13]</xref></p>
        <p>Nipple discharge is associated with&#x000a0;ductal ectasia, intraductal papilloma, or in rare instances, carcinoma.&#x000a0;</p>
        <p>The finding of an intraductal papilloma&#x000a0;is associated with a single duct presenting a bloody, sudden discharge with a small palpable nodule in the retro areolar region. Multiple ducts presenting with&#x000a0;nonspontaneous, green, yellow, clear&#x000a0;discharges are a common feature with&#x000a0;duct ectasia.<xref ref-type="bibr" rid="article-21731.r14">[14]</xref></p>
      </sec>
      <sec id="article-21731.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Triple testing is a combination consisting of clinical examination, imaging, and excision&#x000a0;biopsy. This is essential for all women with a clinical finding, such as a discrete palpable mass.</p>
        <p>Nodularity in young women less than 30 years of age may have management with clinical surveillance and short-term follow-up examination in 2&#x000a0;to 3 months. An investigation may be necessary if the lump has changed on review or if, at the initial presentation, there is a&#x000a0;new change in her breasts.<xref ref-type="bibr" rid="article-21731.r15">[15]</xref>&#x000a0;Nodularity or thickening that is asymmetric in women over the age of 30 years, further investigation utilizing&#x000a0;mammography and ultrasound, is warranted.&#x000a0;</p>
        <p>Short-term&#x000a0;follow-up is an important part of the management of nodularity so that the progression in size of a&#x000a0;mass of nodularity or other associated findings (e.g., skin or nipple changes) is detected.&#x000a0;</p>
        <p>Mammography with ultrasound examination is required for all&#x000a0;discrete palpable lesions in women over 35 to distinguish cysts from solid lesions. Complex cysts containing both fluid and solid matter require biopsy. For solid lesions, radiographically or ultrasonically directed core biopsy provides further information regarding the presence or absence of malignancy.</p>
        <p>Core excision biopsy involves a&#x000a0;cutting needle with&#x000a0;a spring-loaded, automated biopsy instrument that allows sufficient specimen of tissue&#x000a0;for histologic analysis.</p>
        <p>FNA allows&#x000a0;a&#x000a0;cytopathologist to evaluate cellular material.<xref ref-type="bibr" rid="article-21731.r16">[16]</xref>&#x000a0;However, the amount of material retrieved during FNA procedures being sufficient for diagnosis is non-successful in 35 to 47% of non-palpable lesions. A core biopsy is then the recommendation.<xref ref-type="bibr" rid="article-21731.r17">[17]</xref></p>
        <p>Cytology of nipple discharge has limited specificity and sensitivity to&#x000a0;detect&#x000a0;malignancy (35&#x000a0;to 47%). If the results of both clinical and diagnostic evaluations are&#x000a0;benign, a 6&#x000a0;to 12-month&#x000a0;clinical breast examination, ultrasound, and mammography are the suggested follow-up to confirm a stable appearance.&#x000a0;</p>
        <p>A study of 156 patients in Japan who had a benign breast biopsy showed that 13 percent required a subsequent biopsy within two years of having routine FNA procedures performed. In a retrospective study, 150 patients with benign histology after ultrasound-guided vacuum-assisted biopsy for complex cystic breast lesions (BI-RADS 4) were assessed.&#x000a0;</p>
        <p>This subset of patients underwent study in 6 monthly intervals. Of the 104 lesions, none led to the development of malignancy.<xref ref-type="bibr" rid="article-21731.r4">[4]</xref></p>
        <p>Routine ultrasound screening in&#x000a0;Japan was used with&#x000a0;10519 women to evaluate recall criteria.&#x000a0;Researchers noted a cystic-type breast pattern in 6512 cases.</p>
        <p>Only one of the patient cases reported malignancy the following year, related to a solid tumor with a cystic component, proven to be a micro-invasive cancer of less than 1 mm.</p>
        <p>There was no cancer diagnosed in this subset of patients. Most of the study subjects were less than 40 years of age.<xref ref-type="bibr" rid="article-21731.r18">[18]</xref></p>
      </sec>
      <sec id="article-21731.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Due to the role of estrogen and progesterone treatments, promoting fibrocystic changes in the breast, metformin has been suggested as a treatment method to reduce the excessive cell proliferation caused by associated hormones.<xref ref-type="bibr" rid="article-21731.r19">[19]</xref></p>
        <p>For patients presenting with&#x000a0;mastalgia, the first-line options are lifestyle changes. Other suggestions are the use of a supportive bra, as well as altering the dose of&#x000a0;hormone replacement therapy regimen.</p>
        <p>There is no evidence that reducing caffeine improves fibrocystic breast disease or mastalgia.<xref ref-type="bibr" rid="article-21731.r20">[20]</xref><xref ref-type="bibr" rid="article-21731.r21">[21]</xref></p>
        <p>Analgesics such as aspirin and ibuprofen are options.<xref ref-type="bibr" rid="article-21731.r22">[22]</xref></p>
        <p>Researchers have proposed that a deficiency in prostaglandin E and its precursor gamma-linolenic acid (GLA) increase the sensitivity of breasts during&#x000a0;the luteal phase of the menstrual cycle. GLA is subsequently also the active component of evening primrose oil.</p>
        <p>Despite not having proven&#x000a0;efficacy in previous studies, the use of&#x000a0;evening primrose oil is warranted as supportive measures if pain persists despite treatment and advice. A 3 to 6 month period is the suggested&#x000a0;timeframe to observe the desired&#x000a0;effect<xref ref-type="bibr" rid="article-21731.r23">[23]</xref></p>
        <p>If breast pain is severe for more than six months and disrupts daily activities, other therapies such as tamoxifen, bromocriptine, or danazol&#x000a0;can be options. Due to the recurrent nature and long duration of these symptoms, several months of treatment is&#x000a0;necessary.</p>
        <p>Fluid from cysts aspirated for symptomatic relief does not require cytological assessment. This evaluation is reserved for clinically evident lumps that resolve following the FNA procedure or where the cyst fluid appears macroscopically&#x000a0;bloodstained.</p>
        <p>Fluid from atypical cysts should have a cytological assessment.<xref ref-type="bibr" rid="article-21731.r24">[24]</xref></p>
        <p>Surgery is indicated for cysts that repetitively, despite frequent FNA,&#x000a0;which have an&#x000a0;intra-cystic solid appearance on ultrasound or have atypical cells present upon cytopathological evaluation.<xref ref-type="bibr" rid="article-21731.r25">[25]</xref></p>
      </sec>
      <sec id="article-21731.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Breast lump</p>
          </list-item>
          <list-item>
            <p>Breast abscess</p>
          </list-item>
          <list-item>
            <p>Fibrocystic changes</p>
          </list-item>
          <list-item>
            <p>Fibroadenomas</p>
          </list-item>
          <list-item>
            <p>Infections<xref ref-type="bibr" rid="article-21731.r26">[26]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Fat necrosis</p>
          </list-item>
          <list-item>
            <p>Papilloma</p>
          </list-item>
          <list-item>
            <p>Phyllodes tumor</p>
          </list-item>
          <list-item>
            <p>Breast ectasia<xref ref-type="bibr" rid="article-21731.r27">[27]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21731.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <list list-type="order">
          <list-item>
            <p>Thirty patients with fibrocystic breast disease received a clinical trial of danazol.&#x000a0;Twenty-three patients had a 5 to 6-month treatment regime.
<list list-type="bullet"><list-item><p>Partial or complete relief of breast pain and nodularity for all patients included in the clinical trial.</p></list-item><list-item><p>The researchers found malignancy in one patient following&#x000a0;three months of therapy. There were limited reported side effects.</p></list-item><list-item><p>Recurrence of symptoms occurred after discontinuation of the drug.<xref ref-type="bibr" rid="article-21731.r28">[28]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>A study currently being performed in Japan will assess the efficacy and safety of the Xiaoru Sanjie capsule in the treatment of cyclo-mastopathy. The study will be a multicenter, randomized, open controlled clinical study.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21731.s12" sec-type="Staging">
        <title>Staging</title>
        <p>There are not specific characterized stages of benign breast disease used as a standard method of diagnosis; however, fibrocystic type breast disease can be proliferative or non-proliferative types.</p>
        <p>Non-proliferative types are not associated with unexpected cell growth. Common non-proliferative lesions would include:-</p>
        <list list-type="bullet">
          <list-item>
            <p>Periductal fibrosis</p>
          </list-item>
          <list-item>
            <p>Nonsclerosing adenosis</p>
          </list-item>
          <list-item>
            <p>Cysts</p>
          </list-item>
          <list-item>
            <p>Epithelial-related calcifications</p>
          </list-item>
          <list-item>
            <p>Mild epithelial hyperplasia</p>
          </list-item>
          <list-item>
            <p>Papillary apocrine changes.</p>
          </list-item>
        </list>
        <p>Non-proliferative lesions are the most common finding in breast cancer screening biopsies, seen in&#x000a0;70%&#x000a0;of all cases.</p>
        <p>Proliferative changes include factors such as&#x000a0;Intraductal hyperplasia, sclerosing adenosis, radial scars, and papillomas.</p>
      </sec>
      <sec id="article-21731.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Proliferative type lesions have a 1.3 to 1.9 times increased risk of&#x000a0;malignancy for both breasts.</p>
        <p>Any increase in pleomorphic calcifications on mammograms should qualify for a 6-month interval follow-up regime.</p>
      </sec>
      <sec id="article-21731.s14" sec-type="Complications">
        <title>Complications</title>
        <p>A random sampling of fibrocystic breast disease will often reveal fibrosis if fibrosis is detected using MR-guided sampling. Discordant results should be considered, with further evaluation warranted.<xref ref-type="bibr" rid="article-21731.r29">[29]</xref></p>
      </sec>
      <sec id="article-21731.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Advice to be provided to patients for preventing and treating fibrocystic breast disease includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Use over-the-counter pain relievers such as acetaminophen or ibuprofen.</p>
          </list-item>
          <list-item>
            <p>Apply warm or cool compresses to breasts when most painful.</p>
          </list-item>
          <list-item>
            <p>Wear a comfortable, supportive bra.</p>
          </list-item>
          <list-item>
            <p>Avoid large amounts of salt or fat in the diet, which some women find can worsen symptoms.</p>
          </list-item>
          <list-item>
            <p>Consider&#x000a0;an oral contraceptive.</p>
          </list-item>
        </list>
        <p>Check thyroid levels and suggest the use of iodine.</p>
        <p>Consider vitamin E, evening primrose oil, and B vitamins.</p>
      </sec>
      <sec id="article-21731.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>A true lateral mammogram can be useful to distinguish benign calcifications from&#x000a0;malignant calcifications, such as milk of calcium deposits.<xref ref-type="bibr" rid="article-21731.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Diffuse, scattered, similar bilateral findings favor&#x000a0;a benign result.</p>
          </list-item>
          <list-item>
            <p>Focal pain is not a sign of malignancy though ultrasound can serve as a&#x000a0;reassurance tool for patients.</p>
          </list-item>
          <list-item>
            <p>Thermoablation is currently under assessment as a treatment option for&#x000a0;benign and malignant lesions.</p>
          </list-item>
          <list-item>
            <p>The American Society of Breast Surgeons has raised a warning in the&#x000a0;assessment and has released a statement for the&#x000a0;use of ablative treatment.</p>
          </list-item>
          <list-item>
            <p>The statement concludes that&#x000a0;ablative techniques are currently investigational and should not be performed in the United States unless part of a&#x000a0;clinical research trial.<xref ref-type="bibr" rid="article-21731.r31">[31]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21731.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Communicating information about the diagnosis, treatment, and prognosis to patients with breast disease&#x000a0;is important for all reported cases in a breast clinic. The best means to accomplish this is an interprofessional team consisting of primary care providers, general surgeons, radiologists, pharmacists, and specialty-trained breast care nurses.</p>
        <p>Concerns of patients included the language of&#x000a0;physicians, lack of consideration&#x000a0;for patient autonomy, and promotion of&#x000a0;decision-making power to patients.<xref ref-type="bibr" rid="article-21731.r32">[32]</xref></p>
        <p>Pharmacists become involved when using medications to treat this condition. They counsel patients, review side effects, check for drug interactions, and stress the importance of compliance. Breast care nurses educate patients about the good prognosis and the importance of close follow-up initially. They can also chart progress in treatment, or lack thereof, and inform the lead clinician of any concerns that may arise. These examples of interprofessional collaboration show how the team approach can improve patient outcomes and minimize adverse events. [Level 5]&#x000a0;</p>
        <p>Image 4 and 5: Interprofessional care factors to consider during clinical evaluation of breast disease, both benign and malignant findings.</p>
        <p>Psychosocial, home, and work environments require a stable structure to ensure both physical and mental wellbeing. Patients diagnosed with fibrocystic breast disease are also associated with fear and uncertainty due to a lack of education regarding their diagnoses.&#x000a0;</p>
        <p>Proper medical interaction and interprofessional coordination and communication are necessary to ensure a holistic patient output.</p>
      </sec>
      <sec id="article-21731.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21731&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21731">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/fibrocystic-breast-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21731">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21731/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21731">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21731.s19">
        <fig id="article-21731.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Breast Cancer Risk Factors 5. Kerlikowske K, Gard CC, Tice JA, et al. for the Breast Cancer Surveillance Consortium. Risk factors that increase risk of estrogen receptor-positive and -negative breast cancer. J Natl Cancer Inst. 109(5): djw276, 2016.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fibrocystic__disease_Page_2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21731.s20">
        <fig id="article-21731.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Histologic examination of the specimen submitted confirms female breast tissue with adenosis, epithelial hyperplasia, duct dilatation, chronic inflammation and dystrophic calcifications. There is no evidence of in-situ or invasive malignancy on the material examined.
Fibroadenosis with dystrophic calcifications Used with permission and thanks to Lancet Pathology Laboratories, South Africa</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fibroadenosis__with__cal" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21731.s21">
        <fig id="article-21731.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Interprofessional care diagram Breast cancer patients Contributed by Kathryn Malherbe (PhD candidate)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diagram__IPC" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21731.s22">
        <fig id="article-21731.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Post diagnoses attributes in breast cancer patients Contributed by Kathryn Malherbe PhD candidate</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="diagram__2__IPC" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21731.s23">
        <title>References</title>
        <ref id="article-21731.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ameen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Reda</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>El-Shatoury</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Riad</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Enany</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Alarfaj</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of antibiotic resistant mastitis pathogens in dairy cows in Egypt and potential biological control agents produced from plant endophytic actinobacteria.</article-title>
            <source>Saudi J Biol Sci</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>1492</fpage>
            <page-range>1492-1498</page-range>
            <pub-id pub-id-type="pmid">31762615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMullen</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Zoumberos</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Kleer</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>143</volume>
            <issue>12</issue>
            <fpage>1492</fpage>
            <page-range>1492-1496</page-range>
            <pub-id pub-id-type="pmid">31765246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danino</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>El Khatib</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Doucet</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Efanov</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Bou-Merhi</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Iliescu-Nelea</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Preliminary Results Supporting the Bacterial Hypothesis in Red Breast Syndrome following Postmastectomy Acellular Dermal Matrix- and Implant-Based Reconstructions.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>144</volume>
            <issue>6</issue>
            <fpage>988e</fpage>
            <page-range>988e-992e</page-range>
            <pub-id pub-id-type="pmid">31764635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000fc;nemann</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lerda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Follmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alonso-Coello</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Lebeau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nystr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Broeders</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ioannidou-Mouzaka</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Borisch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hofvind</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Castells</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Canelo-Aybar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Warman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mansel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sardanelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Parmelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gr&#x000e4;wingholt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saz-Parkinson</surname>
                <given-names>Z</given-names>
              </name>
              <collab>European Commission Initiative on Breast Cancer (ECIBC) Contributor Group</collab>
            </person-group>
            <article-title>Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.</article-title>
            <source>Ann Intern Med</source>
            <year>2020</year>
            <month>Jan</month>
            <day>07</day>
            <volume>172</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-56</page-range>
            <pub-id pub-id-type="pmid">31766052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sambyal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Guleria</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Uppal</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Manjari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sudan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kukreja</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Risk Factor Analysis for Breast Cancer in Premenopausal and Postmenopausal Women of Punjab, India.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2019</year>
            <month>Nov</month>
            <day>01</day>
            <volume>20</volume>
            <issue>11</issue>
            <fpage>3299</fpage>
            <page-range>3299-3304</page-range>
            <pub-id pub-id-type="pmid">31759352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carvalho</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Subtil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>&#x000c2;</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Figueiredo-Dias</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Controversial association between polycystic ovary syndrome and breast cancer.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>243</volume>
            <fpage>125</fpage>
            <page-range>125-132</page-range>
            <pub-id pub-id-type="pmid">31693949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lundberg</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Iliadou</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Rodriguez-Wallberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gemzell-Danielsson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>ALV</given-names>
              </name>
            </person-group>
            <article-title>The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study.</article-title>
            <source>Eur J Epidemiol</source>
            <year>2019</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>499</fpage>
            <page-range>499-507</page-range>
            <pub-id pub-id-type="pmid">30623293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gopalani</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Janitz</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gutman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Trends in Cancer Incidence Among American Indians and Alaska Natives and Non-Hispanic Whites in the United States, 1999-2015.</article-title>
            <source>Epidemiology</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-213</page-range>
            <pub-id pub-id-type="pmid">31764279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agosto-Arroyo</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Core needle biopsy of benign, borderline and in-situ problematic lesions of the breast: Diagnosis, differential diagnosis and immunohistochemistry.</article-title>
            <source>Ann Diagn Pathol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>43</volume>
            <fpage>151407</fpage>
            <pub-id pub-id-type="pmid">31634810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mullooly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nyante</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Cora</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Butcher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aiello Bowles</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Figueroa</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Weinmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoover</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Brinton</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Berrington de Gonzalez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gierach</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.</article-title>
            <source>J Clin Med</source>
            <year>2019</year>
            <month>Nov</month>
            <day>04</day>
            <volume>8</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">31689948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>[Analysis of common gynecological diseases in 1142 married female workers].</article-title>
            <source>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</source>
            <year>2019</year>
            <month>Oct</month>
            <day>20</day>
            <volume>37</volume>
            <issue>10</issue>
            <fpage>785</fpage>
            <page-range>785-788</page-range>
            <pub-id pub-id-type="pmid">31726513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Autenshlyus</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Studenikina</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bernado</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Mikhailova</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Proskura</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Sidorov</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Varaksin</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lyakhovich</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>[Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].</article-title>
            <source>Biomed Khim</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>418</fpage>
            <page-range>418-423</page-range>
            <pub-id pub-id-type="pmid">31666415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cloete</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Minne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schoub</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>JHR</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging of fibroadenoma-like lesions and correlation with Breast Imaging-Reporting and Data System and Kaiser scoring system.</article-title>
            <source>SA J Radiol</source>
            <year>2018</year>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>1532</fpage>
            <pub-id pub-id-type="pmid">31754520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>QM</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Value of shear wave elastrography image classification in the diagnosis of breast masses].</article-title>
            <source>Zhonghua Zhong Liu Za Zhi</source>
            <year>2019</year>
            <month>Jul</month>
            <day>23</day>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>540</fpage>
            <page-range>540-545</page-range>
            <pub-id pub-id-type="pmid">31357843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jafarian</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kooshkiforooshani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farzad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mohamadian Roshan</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The Relationship Between Fibroblastic Growth Factor Receptor-1 (FGFR1) Gene Amplification in Triple Negative Breast Carcinomas and Clinicopathological Prognostic Factors.</article-title>
            <source>Iran J Pathol</source>
            <year>2019</year>
            <season>Fall</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>299</fpage>
            <page-range>299-304</page-range>
            <pub-id pub-id-type="pmid">31754359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer.</article-title>
            <source>J Cancer</source>
            <year>2019</year>
            <volume>10</volume>
            <issue>24</issue>
            <fpage>6175</fpage>
            <page-range>6175-6184</page-range>
            <pub-id pub-id-type="pmid">31762828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Individualized intervention to improve rates of exclusive breastfeeding: A randomised controlled trial.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>47</issue>
            <fpage>e17822</fpage>
            <pub-id pub-id-type="pmid">31764775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kambe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Konoe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ozaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsubokura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>High internal radiation exposure associated with low socio-economic status six years after the Fukushima nuclear disaster: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>98</volume>
            <issue>47</issue>
            <fpage>e17989</fpage>
            <pub-id pub-id-type="pmid">31764810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers.</article-title>
            <source>J Cancer</source>
            <year>2019</year>
            <volume>10</volume>
            <issue>24</issue>
            <fpage>5992</fpage>
            <page-range>5992-6002</page-range>
            <pub-id pub-id-type="pmid">31762809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x00130;diz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>&#x000c7;ak&#x00131;r</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ulusoy</surname>
                <given-names>A&#x00130;</given-names>
              </name>
              <name>
                <surname>&#x00130;diz</surname>
                <given-names>UO</given-names>
              </name>
            </person-group>
            <article-title>The Role of Nutrition in Women with Benign Cyclic Mastalgia: A Case-Control Study.</article-title>
            <source>Eur J Breast Health</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>156</fpage>
            <page-range>156-159</page-range>
            <pub-id pub-id-type="pmid">30123881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horner</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness.</article-title>
            <source>J Am Diet Assoc</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>11</issue>
            <fpage>1368</fpage>
            <page-range>1368-80</page-range>
            <pub-id pub-id-type="pmid">11103660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahiskalioglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yayik</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ahiskalioglu</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Ekinci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cinal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Preemptive Analgesic Efficacy of the Ultrasound-Guided Bilateral Superficial Serratus Plane Block on Postoperative Pain in Breast Reduction Surgery: A Prospective Randomized Controlled Study.</article-title>
            <source>Aesthetic Plast Surg</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-44</page-range>
            <pub-id pub-id-type="pmid">31741068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Ginsburg</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Folkerd</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Afentakis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quang</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Thi Han</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khoa</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Dinh</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>To</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Clemons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holcombe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Osborne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skene</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sibbering</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Laws</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Noor</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Dowsett</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.</article-title>
            <source>NPJ Breast Cancer</source>
            <year>2019</year>
            <volume>5</volume>
            <fpage>42</fpage>
            <pub-id pub-id-type="pmid">31754627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Mammographic architectural distortion caused by cyst aspiration.</article-title>
            <source>Acta Radiol Open</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>2058460119859353</fpage>
            <pub-id pub-id-type="pmid">31285852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Youlden</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Baade</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pyke</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Roder</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Aitken</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia.</article-title>
            <source>J Adolesc Young Adult Oncol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>402</fpage>
            <page-range>402-409</page-range>
            <pub-id pub-id-type="pmid">31765264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banuelos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sabbagh</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lemaine</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Boughey</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jakub</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hieken</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Degnim</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mandrekar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berbari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sharaf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>144</volume>
            <issue>6</issue>
            <fpage>1270</fpage>
            <page-range>1270-1277</page-range>
            <pub-id pub-id-type="pmid">31764629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fu</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shui</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WT</given-names>
              </name>
            </person-group>
            <article-title>[Low grade adenosquamous carcinoma arising from sclerosing adenosis of the breast: report of a case].</article-title>
            <source>Zhonghua Bing Li Xue Za Zhi</source>
            <year>2019</year>
            <month>May</month>
            <day>08</day>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>415</fpage>
            <page-range>415-417</page-range>
            <pub-id pub-id-type="pmid">31104690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bofill Rodriguez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lethaby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Sep</month>
            <day>19</day>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>CD000400</fpage>
            <pub-id pub-id-type="pmid">31535715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meattini</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Poortmans</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kirova</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saieva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Visani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvestrini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Olmetto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mariotti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desideri</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fourquet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Livi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.</article-title>
            <source>Acta Oncol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-195</page-range>
            <pub-id pub-id-type="pmid">31760849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Urano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shiraki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Denewar</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Toyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shibamoto</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Digital Mammographic Features of Breast Cancer Recurrences and Benign Lesions Mimicking Malignancy Following Breast-Conserving Surgery and Radiation Therapy.</article-title>
            <source>Kurume Med J</source>
            <year>2020</year>
            <month>Jan</month>
            <day>23</day>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>113</fpage>
            <page-range>113-121</page-range>
            <pub-id pub-id-type="pmid">31723078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Copelan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hartman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chehab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Venkatesan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-415</page-range>
            <pub-id pub-id-type="pmid">26622104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21731.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghaemi</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Keshavarz</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tahmasebi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akrami</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heydari</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Explaining Perceived Priorities in Women with Breast Cancer: A Qualitative Study.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2019</year>
            <month>Nov</month>
            <day>01</day>
            <volume>20</volume>
            <issue>11</issue>
            <fpage>3311</fpage>
            <page-range>3311-3319</page-range>
            <pub-id pub-id-type="pmid">31759354</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
